Stay updated on Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Sign up to get notified when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.

Latest updates to the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page
- ChecktodayChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new patch or update to the study record display. This is a technical metadata update that does not alter the study data or visible content.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdds a new bibliographic reference to the Publications section for a 2024 Osteoarthritis Cartilage article on preexisting articular bone pathology in OA patients screened for fasinumab, with the listed authors.SummaryDifference0.0%

- Check22 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a platform or documentation version update. This update does not modify the study details, eligibility criteria, or results; it reflects backend/UI maintenance.SummaryDifference0.0%

- Check44 days agoChange DetectedClinicalTrials.gov’s page footer version was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” indicating a platform/release change rather than a change to the trial record itself.SummaryDifference0.0%

- Check59 days agoChange DetectedOsteoarthritis and related topics (MedlinePlus Genetics) were removed from the page.SummaryDifference0.1%

- Check73 days agoChange DetectedOsteoarthritis is added as a topic and MedlinePlus Genetics is listed as a related topic. This enhances context and discoverability without altering the core study information.SummaryDifference0.1%

Stay in the know with updates to Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.